Skip to main content

A digest of the Evidence-Based Clinical Practice Guideline for Nephrotic Syndrome 2020

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

Acknowledgements

This study was supported in part by a Grant-in-Aid for Intractable Renal Diseases Research, Research on Rare and Intractable Diseases, Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan.

Author information

Affiliations

Authors

Consortia

Corresponding author

Correspondence to Hirokazu Okada.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

In 2020, the Research for Intractable Renal Diseases of the Ministry of Health, Labour and Welfare of Japan established the Committee of Guideline for Nephrotic Syndrome, which published (A Digest from Evidence-Based Clinical Practice Guideline for Nephrotic Syndrome 2020) on the website (jin-shogai.jp/policy/index.html). This is the English version of that digest.

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wada, T., Ishimoto, T., Nakaya, I. et al. A digest of the Evidence-Based Clinical Practice Guideline for Nephrotic Syndrome 2020. Clin Exp Nephrol 25, 1277–1285 (2021). https://doi.org/10.1007/s10157-021-02098-5

Download citation